title: Treatment-related mortality with aflibercept in cancer patients.
authors: Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain, jtabernero@vhio.net.
authors: Josep
authors: J
authors: Tabernero
authors: Simon
authors: S
authors: Hitier
authors: Eric
authors: E
authors: Derobert
authors: Eric
authors: E
authors: Van Cutsem
mesh_terms: D064420:Drug-Related Side Effects and Adverse Reactions / Q000209:etiology*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D040262:Receptors, Vascular Endothelial Growth Factor / Q000009:adverse effects* / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000009:adverse effects* / Q000627:therapeutic use*
chemical_list: D011993:Recombinant Fusion Proteins; D040262:Receptors, Vascular Endothelial Growth Factor